InsiderTrades

Form 4 for HYPR Hyperfine, Inc.

Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-22 · accession 0001104659-21-153339 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-23 2021-12-22 HYPR Hughes Mark A. COO A - Grant — +19.6K 19.6K New —
DM 2021-12-23 2021-12-22 HYPR Hughes Mark A. COO A - Grant — +144.1K 21.3K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-12-22 A A 19,615 — 19,615 D — — (F1) In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub I"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub II"), Hyperfine, Inc., (F2) a Delaware corporation ("Hyperfine"), and Liminal Sciences, Inc., a Delaware corporation ("Liminal"), pursuant to which Merger Sub I merged with and into Hyperfine (the "Hyperfine Merger"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the "Liminal Merger" and, together with the Hyperfine Merger, the "Mergers"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to "Hyperfine, Inc.", the "Issuer"), these shares were received in exchange for 59,894 shares of Hyperfine common stock.
2 Derivative Stock Option (right to buy) 2021-12-22 A A 60,587 — 60,587 D $3.27 · — to 2031-04-14 60,587 Class A Common Stock (F12) Received in connection with the Mergers in exchange for a stock option to acquire 185,000 shares of Hyperfine common stock for $1.07 per share. (F11) The shares underlying this option vest in 48 equal monthly installments beginning on October 31, 2020, subject to Mr. Hughes's continued service through the applicable vesting date.
3 Derivative Stock Option (right to buy) 2021-12-22 A A 4,912 — 4,912 D $3.27 · — to 2031-04-14 4,912 Class A Common Stock (F10) Received in connection with the Mergers in exchange for a stock option to acquire 15,000 shares of Hyperfine common stock for $1.07 per share. (F9) The shares underlying this option vest in 48 equal monthly installments beginning on October 31, 2020, subject to Mr. Hughes's continued service through the applicable vesting date.
4 Derivative Stock Option (right to buy) 2021-12-22 A A 3,275 — 3,275 D $3.76 · — to 2030-01-18 3,275 Class A Common Stock (F8) Received in connection with the Mergers in exchange for a stock option to acquire 10,000 shares of Hyperfine common stock for $1.23 per share. (F7) The shares underlying this option vest as to 25% on December 31, 2020, with the remainder vesting in equal monthly installments, over the following three years, subject to Mr. Hughes's continued service through the applicable vesting date.
5 Derivative Stock Option (right to buy) 2021-12-22 A A 54,037 — 54,037 D $3.76 · — to 2030-01-18 54,037 Class A Common Stock (F6) Received in connection with the Mergers in exchange for a stock option to acquire 165,000 shares of Hyperfine common stock for $1.23 per share. (F5) The shares underlying this option vest as to 25% on December 31, 2020, with the remainder vesting in equal monthly installments, over the following three years, subject to Mr. Hughes's continued service through the applicable vesting date.
6 Derivative Stock Option (right to buy) 2021-12-22 A A 21,322 — 21,322 D $3.76 · — to 2029-07-01 21,322 Class A Common Stock (F4) Received in connection with the Mergers in exchange for a stock option to acquire 65,106 shares of Hyperfine common stock for $1.23 per share. (F3) The shares underlying this option vest as to 25% on September 30, 2020, with the remainder vesting in equal monthly installments, over the following three years, subject to Mr. Hughes's continued service through the applicable vesting date.